$ALT
Altimmune, Inc. Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-K Financial Statement

#000114420414014930 Filed on March 11, 2014

Income Statement

Concept	2012 Q4	2012 Q3	2012 Q2
Revenue	$6.010M	$6.700M	$6.320M
YoY Change	-3.69%	27.38%	-1.71%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.620M	$3.280M	$2.780M
YoY Change	-2.24%	0.0%	-18.48%
% of Gross Profit
Research & Development	$4.750M	$5.139M	$4.919M
YoY Change	4.86%	5.21%	-17.8%
% of Gross Profit
Depreciation & Amortization	$70.00K	$72.45K	$70.00K
YoY Change	-36.36%	-39.62%	-36.36%
% of Gross Profit
Operating Expenses	$7.440M	$8.487M	$7.775M
YoY Change	1.64%	2.47%	-18.24%
Operating Profit	-$1.427M	-$1.790M	-$1.458M
YoY Change	31.83%	-40.75%	-52.68%
Interest Expense	$140.0K	$112.5K	$111.4K
YoY Change	-86.79%	1032.99%	633.89%
% of Operating Profit
Other Income/Expense, Net	$30.00K	$1.599M	$717.8K
YoY Change	-400.0%	-46.51%	11.51%
Pretax Income	-$1.260M	-$191.9K	-$740.4K
YoY Change	-268.0%	472.8%	-69.63%
Income Tax	$10.00K	$22.07K	$16.13K
% Of Pretax Income
Net Earnings	-$1.270M	-$213.9K	-$756.5K
YoY Change	-269.48%	538.69%	-68.96%
Net Earnings / Revenue	-21.13%	-3.19%	-11.97%
Basic Earnings Per Share	-$0.03	$0.00	-$0.02
Diluted Earnings Per Share	-$0.03	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	48.37M shares	48.37M shares	48.33M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q4	2012 Q3	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.70M	$14.70M	$11.80M
YoY Change	13.39%	41.35%	-16.9%
Cash & Equivalents	$12.70M	$14.73M	$11.78M
Short-Term Investments
Other Short-Term Assets	$500.0K	$400.0K	$700.0K
YoY Change	-44.44%	-75.0%	-50.0%
Inventory
Prepaid Expenses
Receivables	$6.500M	$5.300M	$8.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.80M	$20.38M	$20.68M
YoY Change	0.93%	11.36%	-9.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$484.0K	$553.1K	$625.5K
YoY Change	-38.63%	-38.55%	-37.45%
Goodwill	$2.348M	$2.348M	$2.348M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$113.1K	$130.7K	$150.5K
YoY Change	111.92%	30.71%	50.48%
Total Long-Term Assets	$2.946M	$3.032M	$3.124M
YoY Change	-7.68%	-8.11%	-8.1%
TOTAL ASSETS
Total Short-Term Assets	$19.80M	$20.38M	$20.68M
Total Long-Term Assets	$2.946M	$3.032M	$3.124M
Total Assets	$22.74M	$23.41M	$23.81M
YoY Change	-0.27%	8.38%	-9.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.697M	$1.847M	$2.063M
YoY Change	17.4%	361.65%	-17.49%
Accrued Expenses	$2.300M	$3.200M	$3.100M
YoY Change	-14.81%	0.0%	-8.82%
Deferred Revenue
YoY Change
Short-Term Debt	$1.331M	$1.208M	$0.00
YoY Change
Long-Term Debt Due	$750.0K	$681.8K	$454.5K
YoY Change
Total Short-Term Liabilities	$7.488M	$6.971M	$5.659M
YoY Change	62.25%	88.39%	-4.08%
LONG-TERM LIABILITIES
Long-Term Debt	$1.704M	$1.764M	$1.984M
YoY Change
Other Long-Term Liabilities	$579.4K	$579.7K	$564.9K
YoY Change	28.84%	-82.95%	-91.03%
Total Long-Term Liabilities	$2.284M	$2.344M	$2.548M
YoY Change	407.78%	-31.06%	-59.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.488M	$6.971M	$5.659M
Total Long-Term Liabilities	$2.284M	$2.344M	$2.548M
Total Liabilities	$11.07M	$10.86M	$10.26M
YoY Change	59.21%	52.96%	-15.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$198.6M	-$197.3M	-$197.1M
YoY Change	2.54%
Common Stock	$210.5M	$210.1M	$209.7M
YoY Change	0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.67M	$12.55M	$13.55M
YoY Change
Total Liabilities & Shareholders Equity	$22.74M	$23.41M	$23.81M
YoY Change	-0.27%	8.38%	-9.48%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2012 Q2
OPERATING ACTIVITIES
Net Income	-$1.270M	-$213.9K	-$756.5K
YoY Change	-269.48%	538.69%	-68.96%
Depreciation, Depletion And Amortization	$70.00K	$72.45K	$70.00K
YoY Change	-36.36%	-39.62%	-36.36%
Cash From Operating Activities	-$2.140M	$1.730M	-$2.700M
YoY Change	164.2%	-147.92%	107.69%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	120.0K	1.210M	-810.0K
YoY Change	300.0%	-2520.0%	-113.99%
NET CHANGE
Cash From Operating Activities	-2.140M	1.730M	-2.700M
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	120.0K	1.210M	-810.0K
Net Change In Cash	-2.020M	2.940M	-3.510M
YoY Change	-306.12%	-179.46%	-178.7%
FREE CASH FLOW
Cash From Operating Activities	-$2.140M	$1.730M	-$2.700M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$2.140M	$1.730M	-$2.700M
YoY Change	164.2%	-148.46%	112.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53526808	shares
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
CY2012	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale		USD
CY2011	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale	1758960	USD
CY2013Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	65968134	USD
CY2012Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	63586299	USD
CY2013Q4	pip	Equity Offering Remaining Aggregate Sales Available EquityOfferingRemainingAggregateSalesAvailable	8600000	USD
CY2013	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-2585164	USD
CY2012	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	397948	USD
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	69000000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	PHARMATHENE, INC
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Trading Symbol TradingSymbol	PIP
CY2013Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	3182687	USD
CY2012Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2328877	USD
CY2013Q4	pip	Additional Common Stock Aggregate Gross Sales AdditionalCommonStockAggregateGrossSales	8600000	USD
	pip	Common Stock Aggregate Amount Equity Offering CommonStockAggregateAmountEquityOffering	15000000	USD
CY2011	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-14138691	USD
CY2013	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff	6246942	USD
CY2012	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff		USD
CY2011	pip	Income Tax Reconciliation Limitation Deferred Write Off IncomeTaxReconciliationLimitationDeferredWriteOff		USD
CY2013	pip	Lobbying Costs LobbyingCosts	98507	USD
CY2012	pip	Lobbying Costs LobbyingCosts	122204	USD
CY2011	pip	Lobbying Costs LobbyingCosts		USD
CY2012	pip	Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	-1227656	USD
CY2011	pip	Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation		USD
CY2012	pip	Percentage Weight Historical Volitility Company PercentageWeightHistoricalVolitilityCompany	0.5	pure
CY2011	pip	Percentage Weight Historical Volitility Company PercentageWeightHistoricalVolitilityCompany	0.5	pure
	pip	Percentage Weight Historical Volitility Company PercentageWeightHistoricalVolitilityCompany	0.5	pure
	pip	Percentage Weight Historical Volitility Company PercentageWeightHistoricalVolitilityCompany	1	pure
CY2012	pip	Percentage Weight Historical Volitility Comparable Public Companies PercentageWeightHistoricalVolitilityComparablePublicCompanies	0.5	pure
CY2011	pip	Percentage Weight Historical Volitility Comparable Public Companies PercentageWeightHistoricalVolitilityComparablePublicCompanies	0.5	pure
	pip	Percentage Weight Historical Volitility Comparable Public Companies PercentageWeightHistoricalVolitilityComparablePublicCompanies	0.5	pure
CY2013	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale		USD
CY2013	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts		USD
CY2012	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts		USD
CY2011	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	-40524	USD
CY2013	pip	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate	0.12	pure
CY2012	pip	Stock Purchase Warrants Issued In Connection With Issuance Of Long Term Debt StockPurchaseWarrantsIssuedInConnectionWithIssuanceOfLongTermDebt	69876	USD
	pip	Stock Sales Agent Commission Percentage StockSalesAgentCommissionPercentage	0.03	pure
CY2013	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt		USD
CY2012	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt	69876	USD
CY2011	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt		USD
CY2013	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock		USD
CY2012	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock		USD
CY2011	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock	668640	USD
CY2009Q3	pip	Warrant Expiration Date WarrantExpirationDate	2015-01-28
CY2011Q2	pip	Warrant Expiration Date WarrantExpirationDate	2016-06-15
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	1080197	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	1716557	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1128172	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1697280	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1056039	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	365680	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2053517	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1905180	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-218710	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-217328	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	217877117	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	210495905	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1352117	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1803427	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2251501	USD
CY2013Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	1427113	USD
CY2012Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	2432641	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10480979	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12701517	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1362716	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1894099	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2565961	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11600000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11900000	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12000000	shares
CY2013Q4	us-gaap	Assets Assets	17139289	USD
CY2012Q4	us-gaap	Assets Assets	22741404	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	14339108	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	19795845	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11236771	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11785327	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2220538	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1464746	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-548556	USD
CY2011Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	3.50
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5620128	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5620128	shares
CY2011Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5573544	shares
CY2011Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	371423	shares
CY2012Q2	us-gaap	Contracts Revenue ContractsRevenue	6316998	USD
CY2013Q4	us-gaap	Contracts Revenue ContractsRevenue	3653927	USD
CY2012Q1	us-gaap	Contracts Revenue ContractsRevenue	6149052	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52304246	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48352651	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52304246	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48352651	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	5230	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	4835	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong><em>Concentration of Credit Risk</em></strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 15pt; font-size-adjust: none; font-stretch: normal"> <strong><em> </em></strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 15pt; font-size-adjust: none; font-stretch: normal"> Financial instruments that potentially subject us to concentrations of credit risk are primarily cash and cash equivalents, and billed and unbilled accounts receivable. We maintain our cash and cash equivalents in the form of money market accounts and overnight deposits with financial institutions that we believe are credit worthy. Because our billed and unbilled accounts receivable consist of amounts due from the U.S. federal government, management deems there to be minimal credit risk.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Contracts Revenue ContractsRevenue	17912607	USD
CY2012	us-gaap	Contracts Revenue ContractsRevenue	25175887	USD
CY2011	us-gaap	Contracts Revenue ContractsRevenue	24266274	USD
CY2013Q1	us-gaap	Contracts Revenue ContractsRevenue	6475138	USD
CY2013Q2	us-gaap	Contracts Revenue ContractsRevenue	4295400	USD
CY2013Q3	us-gaap	Contracts Revenue ContractsRevenue	3488142	USD
CY2012Q3	us-gaap	Contracts Revenue ContractsRevenue	6696126	USD
CY2012Q4	us-gaap	Contracts Revenue ContractsRevenue	6013711	USD
CY2013	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	20000	USD
CY2012	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	1100000	USD
CY2011	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	700000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	61746	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	195529	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61746	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	195529	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3978944	USD
CY2013Q4	us-gaap	Deferred Revenue DeferredRevenue	341723	USD
CY2012Q4	us-gaap	Deferred Revenue DeferredRevenue	1381755	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	65968134	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67565243	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-257275	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-195497	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61590084	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58334073	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	148395	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	114826	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1726	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3278995	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3368571	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3047573	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	859358	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2789776	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66225409	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	63781796	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3978944	USD
CY2013	us-gaap	Depreciation Depreciation	182487	USD
CY2012	us-gaap	Depreciation Depreciation	303916	USD
CY2011	us-gaap	Depreciation Depreciation	461073	USD
CY2013Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1740235	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1295613	USD
CY2011Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1886652	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	51663	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1688572	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1295613	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1382	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	181	USD
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-208852	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	966207	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	189746	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1300000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1300000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	781760	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3500	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	66626	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13279186	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11628732	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14311079	USD
CY2013Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2012Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	10630	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61746	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-369407	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	388656	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		USD
CY2013	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther		USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11656607	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4724586	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3797573	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195497	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2646910	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-202451	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14138691	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1393366	USD
CY2011	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	732322	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1179476	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-19918	USD
CY2011	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-232489	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign		USD
CY2012	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign		USD
CY2011	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign	-8965832	USD
CY2012	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-193605	USD
CY2011	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-391826	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-710512	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-80292	USD
CY2011	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-50173	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3963246	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1604648	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1291175	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-4745271	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2706156	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4975	USD
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	22101	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1816	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-569120	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	251561	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1682461	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1005528	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1991801	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20748	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	773566	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-418076	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-391904	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1040032	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	867443	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	514312	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-282057	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-367149	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1481150	USD
CY2013	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-1914917	USD
CY2012	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	1093234	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7808553	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-11718353	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-4920115	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-3797573	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111385	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-1236372	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-3945887	USD
CY2013	us-gaap	Loss On Contract Termination LossOnContractTermination	1000000	USD
CY2011	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-987408	USD
CY2013	us-gaap	Interest Expense InterestExpense	369281	USD
CY2012	us-gaap	Interest Expense InterestExpense	342561	USD
CY2011	us-gaap	Interest Expense InterestExpense	54573	USD
CY2013	us-gaap	Interest Paid InterestPaid	234119	USD
CY2012	us-gaap	Interest Paid InterestPaid	220219	USD
CY2011	us-gaap	Interest Paid InterestPaid	54573	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	2575	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	17808	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	16660	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	9803577	USD
CY2012Q4	us-gaap	Liabilities Liabilities	11067564	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17139289	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22741404	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6795981	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7488416	USD
CY2013	us-gaap	License Costs LicenseCosts	40000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	999996	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	749997	USD
CY2013Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1800000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	730279	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1704108	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5030127	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3720071	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5781328	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-81079	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	67400	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1687521	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7168204	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2322906	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-4424709	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-2679888	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-756543	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-213936	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-1269748	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-817399	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1541804	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7928158	USD
CY2013	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2013	us-gaap	Operating Expenses OperatingExpenses	28751815	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	31442277	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	35992005	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-10839208	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-6266390	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-11725731	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1090734	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1481729	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3199182	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5067563	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1590696	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1458204	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1790377	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1427113	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	797700	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	356900	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	846200	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	821600	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	80244	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	56894	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	65660	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113130	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1382	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-194	USD
CY2011	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-239975	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax		USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-1227656	USD
CY2011	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax		USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11719735	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	67400	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3500	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6147965	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4037548	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	588745	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	579427	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6071	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47862	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	39328	USD
CY2013	us-gaap	Paid In Kind Interest PaidInKindInterest	135162	USD
CY2012	us-gaap	Paid In Kind Interest PaidInKindInterest	122342	USD
CY2011	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
CY2013	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	3300000	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	216460	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84579	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71439	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	231491	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547245	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6018891	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	38984	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5855689	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5100000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5900000	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	700000	USD
CY2011Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6500000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities		USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-32960	USD
CY2011	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-74361	USD
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-238767	USD
CY2012	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1330507	USD
CY2011	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit		USD
CY2013	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-749997	USD
CY2012	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	2500000	USD
CY2011	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt		USD
CY2013	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities		USD
CY2012	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	100000	USD
CY2011	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities		USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74796	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38984	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	118309	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2439585	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2389156	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	386068	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	483976	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3600000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15290142	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19509629	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21219853	USD
CY2013	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	10599	USD
CY2012	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	57712	USD
CY2011	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	240111	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-210327925	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198609572	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1362716	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	1894099	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2565961	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y7M6D
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0118	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0279	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0096	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0079	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0079	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.86	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.86	pure
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.83	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	35000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.23
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.86
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.17
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1600000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1400000	USD
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2100000	USD
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2300000	USD
CY2011Q2	us-gaap	Share Price SharePrice	3.5
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1091740	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1330507	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	7335712	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	12210705	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	11673840	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	15851806	USD
CY2010Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	6700000	shares
CY2010Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1900000	shares
CY2011Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1857143	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3883173	shares
CY2010Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	17000000	USD
CY2010Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4800000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5944095	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5068728	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74796	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	38984	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	118309	USD
CY2013Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	2199525	USD
CY2012Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	4114442	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-444622	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	591039	USD
CY2011	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7144983	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong><em>Use of Estimates</em></strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 15pt; font-size-adjust: none; font-stretch: normal"> <strong><em> </em></strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 15pt; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our consolidated financial statements include significant estimates for the expected economic life and value of our tangible assets and value of our intangible asset, the amount of our net operating losses, our share-based compensation, and financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal">   </p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50659116	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48323067	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47331763	shares

Files In Submission

Name	View Source	Status
0001144204-14-014930-index-headers.html	Edgar Link	pending
0001144204-14-014930-index.html	Edgar Link	pending
0001144204-14-014930.txt	Edgar Link	pending
0001144204-14-014930-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_004.jpg	Edgar Link	pending
pip-20131231.xml	Edgar Link	completed
pip-20131231.xsd	Edgar Link	pending
pip-20131231_cal.xml	Edgar Link	unprocessable
pip-20131231_def.xml	Edgar Link	unprocessable
pip-20131231_lab.xml	Edgar Link	unprocessable
pip-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v367765_10k.htm	Edgar Link	pending
v367765_ex23.htm	Edgar Link	pending
v367765_ex31-1.htm	Edgar Link	pending
v367765_ex31-2.htm	Edgar Link	pending
v367765_ex32-1.htm	Edgar Link	pending
v367765_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune, Inc. Stock $alt

2012 Q4 Form 10-K Financial Statement

#000114420414014930 Filed on March 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune, Inc. Stock $alt

2012 Q4 Form 10-K Financial Statement

#000114420414014930 Filed on March 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune, Inc. Stock $alt